RISPERDAL 25 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1123600310397 -
GGREM
514518050034503 -
Código de barras
7896212425570
O que a fonte publica
- Detentor do registro
- JANSSEN-CILAG FARMACEUTICA LTDA
- Princípios ativos
- RISPERIDONA
- Embalagem
- 25 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Novo
- Classe terapêutica
- N5A1 - ANTIPSICÓTICOS ATÍPICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- RISPERDAL 25 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT
- RISPERDAL
- RISPERIDONA
Dados completos da fonte
{
"name": "RISPERDAL 25 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT",
"holder": "JANSSEN-CILAG FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896212425570"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "514518050034503",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "51.780.468/0001-87",
"priceRegime": "Regulado",
"productName": "RISPERDAL",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "25 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "1010.14",
"icms-12": "1147.89",
"icms-17": "1217.04",
"icms-18": "1231.88",
"icms-19": "1247.09",
"icms-20": "1262.68",
"icms-21": "1278.66",
"icms-22": "1295.05",
"icms-23": "1311.87",
"icms-17.5": "1224.41",
"icms-19.5": "1254.83",
"icms-20.5": "1270.62",
"icms-22.5": "1303.41",
"icms-12-alc": "1134.11",
"icms-17-alc": "1202.43",
"icms-18-alc": "1217.10",
"icms-19-alc": "1232.12",
"icms-20-alc": "1247.52",
"icms-21-alc": "1263.31",
"icms-22-alc": "1279.51",
"icms-23-alc": "1296.13",
"withoutTaxes": "998.02",
"icms-17.5-alc": "1209.72",
"icms-19.5-alc": "1239.77",
"icms-20.5-alc": "1255.37",
"icms-22.5-alc": "1287.77"
},
"pisCofinsList": "Positiva",
"substanceText": "RISPERIDONA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1392.37",
"icms-12": "1582.25",
"icms-17": "1677.56",
"icms-18": "1698.02",
"icms-19": "1718.98",
"icms-20": "1740.47",
"icms-21": "1762.50",
"icms-22": "1785.09",
"icms-23": "1808.28",
"icms-17.5": "1687.72",
"icms-19.5": "1729.65",
"icms-20.5": "1751.42",
"icms-22.5": "1796.61",
"icms-12-alc": "1567.84",
"icms-17-alc": "1662.29",
"icms-18-alc": "1682.57",
"icms-19-alc": "1703.33",
"icms-20-alc": "1724.62",
"icms-21-alc": "1746.45",
"icms-22-alc": "1768.85",
"icms-23-alc": "1791.82",
"withoutTaxes": "1379.70",
"icms-17.5-alc": "1672.37",
"icms-19.5-alc": "1713.91",
"icms-20.5-alc": "1735.48",
"icms-22.5-alc": "1780.27"
},
"invalidBarcodes": [],
"activeSubstances": [
"RISPERIDONA"
],
"therapeuticClass": "N5A1 - ANTIPSICÓTICOS ATÍPICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1123600310397",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N5A1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:514518050034503"